<DOC>
	<DOCNO>NCT00448929</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness trabeculectomy ologen ( OculusGen ) Biodegradable Collagen Matrix Implant trabeculectomy without antifibrotic agent .</brief_summary>
	<brief_title>Ologen ( OculusGen ) -Glaucoma Case Control Trial India</brief_title>
	<detailed_description>1 . Study Objective : To determine safety effectiveness ologen ( OculusGen ) Biodegradable Collagen Matrix Implant filtration surgery . The primary endpoint prove effectiveness via reduction IOP , secondary endpoint prove safety via incidence complication adverse event . 2 . Study Design : The study design open-label , randomize , parallel , comparative study . Patients meet inclusion/exclusion criterion sign inform consent include . After enrollment , patient randomize two group : trabeculectomy OculusGen implant trabeculectomy without antifibrotics . 3 . Follow-Up : There 7 post-operative follow-up visit within 6 month surgery : postoperative day 1 , 7 , 14 , 30 , 60 , 90 180 . A window ± 7 day allow 30 , 60 , 90 day visit ± 14 day 180 day visit . Further follow-up subject trial responsibility investigator .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Age 30 year . No previous intraocular operative surgery Uncontrolled glaucoma , fail medical laser treatment , require trabeculectomy . Subject able willing cooperate investigation plan . Subject able willing complete postoperative followup requirement . Subject willing sign inform consent form . Known allergic reaction porcine collagen . Subject warfarin discontinuation recommend . Patient diagnose one follow glaucoma : normal tension glaucoma , uveitic glaucoma , aphakia pseudophakia glaucoma , neovascular glaucoma classify secondary glaucoma . Participation investigational study 30 day proceed trabeculectomy . Ocular infection within 14 day prior trabeculectomy . Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Collagen matrix</keyword>
	<keyword>ologen</keyword>
	<keyword>OculusGen</keyword>
	<keyword>Trabeculectomy</keyword>
</DOC>